Illumina already had multiple chips on the market for use in constitutional and cancer cytogenetic testing as well as its own internally developed data analysis platform, KaryoStudio, when it snatched up Cambridge, UK-based BlueGnome for an undisclosed sum in September, gaining Blue-Gnome's widely used BlueFuse software in the deal as well as its range of CytoChips, which are used in everything from prenatal testing to screening embryos prior to implantation in in vitro fertilization cycles.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.